Literature DB >> 26375877

Cancer statistics for Hispanics/Latinos, 2015.

Rebecca L Siegel1, Stacey A Fedewa2, Kimberly D Miller3, Ann Goding-Sauer3, Paulo S Pinheiro4, Dinorah Martinez-Tyson5, Ahmedin Jemal6.   

Abstract

Cancer is the leading cause of death among Hispanics/Latinos, who represent the largest racial/ethnic minority group in the United States, accounting for 17.4% (55.4 million/318 million) of the total US population in 2014. Every 3 years, the American Cancer Society reports on cancer statistics for Hispanics based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. Among Hispanics in 2015, there will be an estimated 125,900 new cancer cases diagnosed and 37,800 cancer deaths. For all cancers combined, Hispanics have 20% lower incidence rates and 30% lower death rates compared with non-Hispanic whites (NHWs); however, death rates are slightly higher among Hispanics during adolescence (aged 15-19 years). Hispanic cancer rates vary by country of origin and are generally lowest in Mexicans, with the exception of infection-associated cancers. Liver cancer incidence rates in Hispanic men, which are twice those in NHW men, doubled from 1992 to 2012; however, rates in men aged younger than 50 years declined by 43% since 2003, perhaps a bellwether of future trends for this highly fatal cancer. Variations in cancer risk between Hispanics and NHWs, as well as between subpopulations, are driven by differences in exposure to cancer-causing infectious agents, rates of screening, and lifestyle patterns. Strategies for reducing cancer risk in Hispanic populations include increasing the uptake of preventive services (e.g., screening and vaccination) and targeted interventions to reduce obesity, tobacco use, and alcohol consumption.
© 2015 American Cancer Society.

Entities:  

Keywords:  Hispanic; Latino; statistics; surveillance

Mesh:

Year:  2015        PMID: 26375877     DOI: 10.3322/caac.21314

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  182 in total

1.  Implementation of PD-L1 22C3 IHC pharmDxTM in Cell Block Preparations of Lung Cancer: Concordance with Surgical Resections and Technical Validation of CytoLyt® Prefixation.

Authors:  Si Kei Lou; Hyang Mi Ko; Tomonari Kinoshita; Scott MacDonald; Jessica Weiss; Katarzyna Czarnecka-Kujawa; Scott L Boerner; Kazuhiro Yasufuku; Ming-Sound Tsao; Joerg Schwock
Journal:  Acta Cytol       Date:  2020-06-29       Impact factor: 2.319

2.  MiR-491-5p negatively regulates cell proliferation and motility by targeting PDGFRA in prostate cancer.

Authors:  Yanjun Xu; Rui Hou; Qijie Lu; Yang Zhang; Lei Chen; Yuanyi Zheng; Bing Hu
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

3.  'Simple and easy:' providers' and latinos' perceptions of the fecal immunochemical test (FIT) for colorectal cancer screening.

Authors:  Claudia X Aguado Loi; Dinorah Martinez Tyson; Enmanuel A Chavarria; Liliana Gutierrez; Lynne Klasko; Stacy Davis; Diana Lopez; Tracy Johns; Cathy D Meade; Clement K Gwede
Journal:  Ethn Health       Date:  2018-01-10       Impact factor: 2.772

4.  Understanding the supportive care needs of Hispanic men cancer survivors.

Authors:  Dinorah Dina Martinez Tyson; Coralia Vázquez-Otero; Patricia Medina-Ramirez; Nora B Arriola; Susan C McMillan; Clement K Gwede
Journal:  Ethn Health       Date:  2016-06-27       Impact factor: 2.772

5.  miR-221 regulates proliferation and apoptosis of ovarian cancer cells by targeting BMF.

Authors:  Xinping Xie; Yuxiu Huang; Lihong Chen; Jinhua Wang
Journal:  Oncol Lett       Date:  2018-09-18       Impact factor: 2.967

6.  Educating Hispanic Women about Cervical Cancer Prevention: Feasibility of a Promotora-Led Charla Intervention in a Farmworker Community.

Authors:  Khaliah Fleming; Vani N Simmons; Shannon M Christy; Steven K Sutton; Margarita Romo; John S Luque; Kristen J Wells; Clement K Gwede; Cathy D Meade
Journal:  Ethn Dis       Date:  2018-07-12       Impact factor: 1.847

7.  Differences in Prevalence of Large Polyps Between Hispanic Americans from Mexican- and Non-Mexican-Predominant States.

Authors:  Danny J Avalos; Marc J Zuckerman; Alok Dwivedi; Christopher Dodoo; Jinendra Satiya; Fernando J Castro
Journal:  Dig Dis Sci       Date:  2018-10-01       Impact factor: 3.199

8.  An Investigation into the Recent Increase in Gastric Cancer in the USA.

Authors:  Maya Balakrishnan; Rollin George; Ashish Sharma; David Y Graham; Hoda M Malaty
Journal:  Dig Dis Sci       Date:  2018-03-15       Impact factor: 3.199

9.  Barriers to and Interest in Lung Cancer Screening Among Latino and Non-Latino Current and Former Smokers.

Authors:  Sanja Percac-Lima; Jeffrey M Ashburner; Steven J Atlas; Nancy A Rigotti; Efren J Flores; Salome Kuchukhidze; Elyse R Park
Journal:  J Immigr Minor Health       Date:  2019-12

10.  Recommendations for Cancer Epidemiologic Research in Understudied Populations and Implications for Future Needs.

Authors:  Damali N Martin; Tram Kim Lam; Katy Brignole; Kimlin T Ashing; William J Blot; Linda Burhansstipanov; Jarvis T Chen; Mark Dignan; Scarlett Lin Gomez; Maria Elena Martinez; Alicia Matthews; Julie R Palmer; Eliseo J Perez-Stable; Mario Schootman; Hugo Vilchis; Alexander Vu; Shobha Srinivasan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-04       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.